- Home
- NEUE
NEUE
NEUEHEALTH INC
as 07-26-2024 4:00pm EST
Stocks
NeueHealth Inc is a value driven healthcare company grounded in the belief that all health consumers are entitled to high-quality, coordinated care. By uniquely aligning the interests of health consumers, providers, and payors, NeueHealth helps to make healthcare accessible and affordable to all populations across the ACA Marketplace, Medicare, and Medicaid. It also enables independent providers and medical groups to thrive in performance-based arrangements through a suite of technology and services scaled centrally and deployed locally.
| Founded: | 2015 | Country: | United States |
| Employees: | N/A | City: | DORAL |
| Market Cap: | 43.0M | IPO Year: | 2021 |
| Target Price: | $8.00 | AVG Volume (30 days): | 27.0K |
| Analyst Decision: | Hold | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -130.59 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.94 - $22.00 | Next Earning Date: | 08-07-2024 |
| Revenue: | $1,105,347,000 | Revenue Growth: | 26.91% |
| Revenue Growth (this year): | -12.04% | Revenue Growth (next year): | 10.38% |
Stock Insider Trading Activity of NEUEHEALTH INC (NEUE)
| Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Matushak Jay | NEUE | Chief Financial Officer | May 9 '24 | Sell | $6.05 | 317 | $1,917.85 | 9,304 | SEC Form 4 |
| Scherman Jeffrey J | NEUE | Chief Accounting Officer | May 9 '24 | Sell | $6.05 | 113 | $683.65 | 3,670 | SEC Form 4 |
| Scherman Jeffrey J | NEUE | Chief Accounting Officer | Mar 18 '24 | Sell | $7.27 | 568 | $4,129.36 | 3,440 | SEC Form 4 |
| Orozco Tomas | NEUE | EVP, Consumer Care | Mar 18 '24 | Sell | $7.27 | 822 | $5,975.94 | 5,092 | SEC Form 4 |
| Matushak Jay | NEUE | Chief Financial Officer | Mar 18 '24 | Sell | $7.27 | 1,083 | $7,873.41 | 8,643 | SEC Form 4 |
| Mikan George Lawrence III | NEUE | CEO & President | Mar 18 '24 | Sell | $7.27 | 4,990 | $36,277.30 | 64,832 | SEC Form 4 |
| Craig Jeffery Michael | NEUE | GC & Corporate Secretary | Mar 18 '24 | Sell | $7.27 | 260 | $1,890.20 | 3,426 | SEC Form 4 |
| Orozco Tomas | NEUE | EVP, Consumer Care | Mar 14 '24 | Sell | $7.06 | 54 | $381.24 | 5,993 | SEC Form 4 |
| Orozco Tomas | NEUE | EVP, Consumer Care | Mar 14 '24 | Sell | $7.10 | 79 | $560.90 | 5,914 | SEC Form 4 |
| Mikan George Lawrence III | NEUE | CEO & President | Mar 14 '24 | Sell | $7.06 | 2,398 | $16,929.88 | 73,264 | SEC Form 4 |
| Mikan George Lawrence III | NEUE | CEO & President | Mar 14 '24 | Sell | $7.10 | 3,442 | $24,438.20 | 69,822 | SEC Form 4 |
| Craig Jeffery Michael | NEUE | GC & Corporate Secretary | Mar 14 '24 | Sell | $7.06 | 105 | $741.30 | 3,837 | SEC Form 4 |
| Craig Jeffery Michael | NEUE | GC & Corporate Secretary | Mar 14 '24 | Sell | $7.10 | 151 | $1,072.10 | 3,686 | SEC Form 4 |
| Scherman Jeffrey J | NEUE | Chief Accounting Officer | Mar 14 '24 | Sell | $7.06 | 68 | $480.08 | 4,106 | SEC Form 4 |
| Scherman Jeffrey J | NEUE | Chief Accounting Officer | Mar 14 '24 | Sell | $7.10 | 98 | $695.80 | 4,008 | SEC Form 4 |
| Matushak Jay | NEUE | Chief Financial Officer | Mar 14 '24 | Sell | $7.06 | 173 | $1,221.38 | 9,974 | SEC Form 4 |
| Matushak Jay | NEUE | Chief Financial Officer | Mar 14 '24 | Sell | $7.10 | 248 | $1,760.80 | 9,726 | SEC Form 4 |
| Matushak Jay | NEUE | Chief Financial Officer | Mar 11 '24 | Sell | $8.11 | 193 | $1,565.23 | 10,514 | SEC Form 4 |
| Matushak Jay | NEUE | Chief Financial Officer | Mar 11 '24 | Sell | $7.76 | 116 | $900.16 | 10,398 | SEC Form 4 |
| Matushak Jay | NEUE | Chief Financial Officer | Mar 11 '24 | Sell | $7.30 | 251 | $1,832.30 | 10,147 | SEC Form 4 |
| Craig Jeffery Michael | NEUE | GC & Corporate Secretary | Mar 11 '24 | Sell | $8.11 | 117 | $948.87 | 4,164 | SEC Form 4 |
| Craig Jeffery Michael | NEUE | GC & Corporate Secretary | Mar 11 '24 | Sell | $7.76 | 70 | $543.20 | 4,094 | SEC Form 4 |
| Craig Jeffery Michael | NEUE | GC & Corporate Secretary | Mar 11 '24 | Sell | $7.30 | 152 | $1,109.60 | 3,942 | SEC Form 4 |
| Orozco Tomas | NEUE | EVP, Consumer Care | Mar 11 '24 | Sell | $8.11 | 60 | $486.60 | 6,161 | SEC Form 4 |
| Orozco Tomas | NEUE | EVP, Consumer Care | Mar 11 '24 | Sell | $7.76 | 36 | $279.36 | 6,125 | SEC Form 4 |
Latest NEUEHEALTH INC News
NEUE Breaking Stock News: Dive into NEUE Ticker-Specific Updates for Smart Investing
Business Wire
8 days ago
NeueHealth to Host Second Quarter 2024 Earnings Conference Call on August 7, 2024
Business Wire
a month ago
NeueHealth Secures up to $150 Million in New Term Loan Facility with Hercules Capital
Business Wire
a month ago
NeueHealth Receives NYSE Non-Compliance Letter Regarding Market Capitalization Requirements
Business Wire
3 months ago
NeueHealth Reports First Quarter 2024 Results
Business Wire
3 months ago
NeueHealth to Host First Quarter 2024 Earnings Conference Call on May 8, 2024
Business Wire
4 months ago
NeueHealth Enters into Amendment to its Credit Facility
Business Wire
5 months ago
NeueHealth Reports Fourth Quarter and Full Year 2023 Results
Business Wire
5 months ago
NeueHealth to Host Fourth Quarter 2023 Earnings Conference Call on March 6, 2024
Compare NEUE vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "NEUE NEUEHEALTH INC - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.